Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992816826> ?p ?o ?g. }
- W1992816826 endingPage "688" @default.
- W1992816826 startingPage "684" @default.
- W1992816826 abstract "<b><i>Background:</i></b> The reduction of <i>N</i>-acetylaspartate (NAA) detected by proton MR spectroscopy (<sup>1</sup>H-MRS) represents a robust but unspecific marker for neuronal loss or dysfunction. <b><i>Objective:</i></b> To apply <sup>1</sup>H-MRS in two brain regions that reflect the characteristic spatial distribution of neuronal loss in AD. These regions are the medial temporal lobe (MTL), which is affected early in AD, and the primary motor and sensory cortex (central region), which is affected late in the disease and might serve as an intraindividual control region in mild to moderate disease stages. <b><i>Methods:</i></b> Twenty patients and 18 volunteers underwent <sup>1</sup>H-MRS in both brain areas. The metabolic ratios of NAA/creatine and choline/creatine were determined. Additionally, the metabolic ratios of the MTL were divided by the ratios of the central region to assess the relative change in the MTL in individual subjects. All ratios were correlated with psychometric test scores. <b><i>Results:</i></b> A significant reduction of NAA/creatine and choline/creatine ratios was detected in the MTL of patients with AD. In the central region, no significant difference between the groups was found. NAA/creatine (MTL/central region) was reduced in patients with AD and showed a correlation with the Mini-Mental State Examination and the cognitive part of the Alzheimer Disease Assessment Scale scores. Choline/creatine (MTL/central region) did not show a significant difference between groups. <b><i>Conclusion:</i></b> Assessing the distribution of NAA/creatine reduction guided by the expected neuropathologic change can improve the role of <sup>1</sup>H-MRS in the assessment of AD. The disease severity can be monitored by relative reduction of NAA/creatine in the MTL in comparison with an intraindividual unaffected control region." @default.
- W1992816826 created "2016-06-24" @default.
- W1992816826 creator A5021586531 @default.
- W1992816826 creator A5037417204 @default.
- W1992816826 creator A5040206867 @default.
- W1992816826 creator A5065253382 @default.
- W1992816826 creator A5065722649 @default.
- W1992816826 creator A5075113890 @default.
- W1992816826 creator A5077299496 @default.
- W1992816826 creator A5083545194 @default.
- W1992816826 creator A5085343325 @default.
- W1992816826 date "2000-09-12" @default.
- W1992816826 modified "2023-10-01" @default.
- W1992816826 title "Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD" @default.
- W1992816826 cites W1847168837 @default.
- W1992816826 cites W1953027527 @default.
- W1992816826 cites W1969037453 @default.
- W1992816826 cites W1973648620 @default.
- W1992816826 cites W1990039754 @default.
- W1992816826 cites W1990559915 @default.
- W1992816826 cites W2002932861 @default.
- W1992816826 cites W2005176833 @default.
- W1992816826 cites W2007156170 @default.
- W1992816826 cites W2031807806 @default.
- W1992816826 cites W2032971442 @default.
- W1992816826 cites W2033800655 @default.
- W1992816826 cites W2038419059 @default.
- W1992816826 cites W2041222049 @default.
- W1992816826 cites W2042514413 @default.
- W1992816826 cites W2052742260 @default.
- W1992816826 cites W2053745540 @default.
- W1992816826 cites W2058027749 @default.
- W1992816826 cites W2064243689 @default.
- W1992816826 cites W2083589763 @default.
- W1992816826 cites W2084424457 @default.
- W1992816826 cites W2091108530 @default.
- W1992816826 cites W2091871569 @default.
- W1992816826 cites W2092032633 @default.
- W1992816826 cites W2095868324 @default.
- W1992816826 cites W2117312470 @default.
- W1992816826 cites W2139806709 @default.
- W1992816826 cites W2141439680 @default.
- W1992816826 cites W2143854933 @default.
- W1992816826 cites W2156220037 @default.
- W1992816826 cites W2164398286 @default.
- W1992816826 cites W2164938294 @default.
- W1992816826 cites W2170844930 @default.
- W1992816826 cites W2184566069 @default.
- W1992816826 doi "https://doi.org/10.1212/wnl.55.5.684" @default.
- W1992816826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10980734" @default.
- W1992816826 hasPublicationYear "2000" @default.
- W1992816826 type Work @default.
- W1992816826 sameAs 1992816826 @default.
- W1992816826 citedByCount "155" @default.
- W1992816826 countsByYear W19928168262012 @default.
- W1992816826 countsByYear W19928168262013 @default.
- W1992816826 countsByYear W19928168262014 @default.
- W1992816826 countsByYear W19928168262015 @default.
- W1992816826 countsByYear W19928168262016 @default.
- W1992816826 countsByYear W19928168262017 @default.
- W1992816826 countsByYear W19928168262018 @default.
- W1992816826 countsByYear W19928168262019 @default.
- W1992816826 countsByYear W19928168262020 @default.
- W1992816826 countsByYear W19928168262021 @default.
- W1992816826 countsByYear W19928168262022 @default.
- W1992816826 countsByYear W19928168262023 @default.
- W1992816826 crossrefType "journal-article" @default.
- W1992816826 hasAuthorship W1992816826A5021586531 @default.
- W1992816826 hasAuthorship W1992816826A5037417204 @default.
- W1992816826 hasAuthorship W1992816826A5040206867 @default.
- W1992816826 hasAuthorship W1992816826A5065253382 @default.
- W1992816826 hasAuthorship W1992816826A5065722649 @default.
- W1992816826 hasAuthorship W1992816826A5075113890 @default.
- W1992816826 hasAuthorship W1992816826A5077299496 @default.
- W1992816826 hasAuthorship W1992816826A5083545194 @default.
- W1992816826 hasAuthorship W1992816826A5085343325 @default.
- W1992816826 hasConcept C118552586 @default.
- W1992816826 hasConcept C126322002 @default.
- W1992816826 hasConcept C134018914 @default.
- W1992816826 hasConcept C142724271 @default.
- W1992816826 hasConcept C15744967 @default.
- W1992816826 hasConcept C169760540 @default.
- W1992816826 hasConcept C2777348757 @default.
- W1992816826 hasConcept C2778186239 @default.
- W1992816826 hasConcept C2779281540 @default.
- W1992816826 hasConcept C2779896295 @default.
- W1992816826 hasConcept C2781099131 @default.
- W1992816826 hasConcept C2781123555 @default.
- W1992816826 hasConcept C71924100 @default.
- W1992816826 hasConceptScore W1992816826C118552586 @default.
- W1992816826 hasConceptScore W1992816826C126322002 @default.
- W1992816826 hasConceptScore W1992816826C134018914 @default.
- W1992816826 hasConceptScore W1992816826C142724271 @default.
- W1992816826 hasConceptScore W1992816826C15744967 @default.
- W1992816826 hasConceptScore W1992816826C169760540 @default.
- W1992816826 hasConceptScore W1992816826C2777348757 @default.
- W1992816826 hasConceptScore W1992816826C2778186239 @default.
- W1992816826 hasConceptScore W1992816826C2779281540 @default.